Data supplement for Allen et al., Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis. Am J Psychiatry (doi: 10.1176/appi.ajp.2015.15040485) Supplementary Information Title: Resting hyperperfusion of the hippocampus, midbrain and striatum in people at ultra high risk for psychosis Authors: Paul Allen 1 3 *, Chris Chaddock 1 *, Alice Egerton 1 *, Oliver Howes 1, Ilria Bonoldi 1, Fernando Zelaya 2, Sagnik Bhattacharyya 1, Robin Murray 1 & Philip McGuire 1 * = These authors contributed equally to the paper Affiliations 1 Department of Psychology, University of Roehampton, London, United Kingdom 2 Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom 3 Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom Corresponding author: Paul Allen Institute of Psychiatry, Psychology & Neuroscience, King s College London (PO67) 16 De Crespigny Park, London SE5 8AF, UK. Telephone: 0044 (0)2078480958 Email p.allen@kcl.ac.uk Disclosure and Acknowledgements ODH has received unrestricted investigator-led charitable funding from or spoken at meetings organised by Astra-Zeneca, Bristol-Myers Squibb, Jenssen, Hoffman la Roche, Leyden-Delta and Eli Lilly. RM has received honoraria from Jenssen, Lilly, Astra-Zeneca and Roche. PM has received consultancy fees from Hoffman la Roche and Sunovion. This study was funded by a Medical Research Council (MRC) UK research grant (no. G0700995). We would like to thank
members of the Outreach and Support in South London (OASIS) team who were involved in the recruitment, management and clinical follow-up of the ultra-high risk subjects who participated in this study. METHODS Neuroimaging protocol Subjects were scanned with their eyes open using a General Electric Signa HDX 3.0T scanner, fitted with a receive only 8-channel phased array head coil at the Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience. For image registration both a high resolution T2-weighted Fast Spin Echo (FSE) image (0.468x0.468x4mm, TE=54.58ms, TR=4380ms, Flip angle 90deg, FoV=240) and a high-resolution T1-weighted Spoiled Gradient Recalled (SPGR) image (1.1x1.1x1.1mm, TE=2.848, TR=7.144ms, Flip angle=20deg, FoV=280) were acquired. Resting Cerebral Blood Flow (rcbf) was measured using Continuous Arterial Spin Labelling (CASL) scans acquired with a 3D Fast Spin Echo (FSE) spiral multi-shot readout, following a post-labelling delay of 1.5s. This delay has been appropriate for investigations in participants of a similar age range as the ones included in this study. The spiral acquisition used a short (4ms) TE, and 8 spiralarms (interleaves) with 512 points in each arm. (FSE TE 32ms/TR = 5500ms; ETL = 64). Images were reconstructed to a 256 2 matrix, giving a final spatial resolution of 1x1 mm in plane. 60 slices of 3mm thickness were obtained. Three pairs of tagged-untagged images were collected. Background suppression included selective saturation of the image slab at 4.3s before acquisition,
selective inversion 3s before acquisition and non-selective inversions at 1.5s, 764ms, 334ms and 84ms before imaging. This repeated inversion achieved successful suppression of the background static tissue signal, maximizing the sensitivity to blood perfusion. Calibration images were collected with the same imaging sequence but with inversion recovery preparation instead of CASL. One sequence with saturation of 4.3s and then an inversion at 1650 ms before imaging was used to create a fluid suppressed image. A second sequence with saturation at 4.3s and then inversion at both 2408ms and 511ms was also acquired to create a fluid and white matter suppressed image. For both these sequences, the receiver gain was automatically lowered by 21 db relative to the ASL sequence to avoid receiver saturation. These images were used to quantify blood flow in physiological units (ml blood/100gm tissue/min). The sensitivity of the image to water was calibrated at each voxel 1-3. When multi-channel coils are employed, the spatially non-uniform sensitivity complicates this calibration. Often the underlying tissue signal is used as an indicator of water sensitivity, but a water density in each voxel, or partition coefficient, must then be assumed. We observed that the signal intensity in the inversion-prepared fluid-suppressed image was relatively constant for different tissues. This is likely because more complete recovery occurs for shorter T1 tissues, which tend to have lower water density. Using a neighborhood maximum algorithm to avoid regions with partial volume of suppressed fluid, a lowresolution sensitivity map was created. This map was calibrated for water sensitivity by assuming the tissue was white matter with a water concentration
of 0.735 gm/ml 4 and a T1 of 900ms, and using the equations for inversion recovery signal attenuation. By assuming gray matter with a water concentration of 0.88 gm/ml and a T1 of 1150 there was only a 5% calibration difference. This calibration produced a sensitivity map, C, equal to the fully relaxed MRI signal intensity produced by 1gm of water per ml of brain tissue. With this co-registered sensitivity map C, we calculated cerebral blood flow (CBF) using the equation: Where ρb is 1.05g/ml (the density of brain tissue; 4, α is the labeling efficiency (assumed to be 95% for labeling times 75% for background suppression; 5, w is 1.5s (the post-labeling delay; 2, tl is 500ms (the labeling duration), T1a is 1.4 ms (the T1 of arterial blood which was slightly lower than the value of Lu et al. 2004), ωa 0.85 g/ml (the density of water in blood; 4, Sl and Sc are the signal intensities in the labeled and control images, respectively). The whole ASL pulse sequence, including the acquisition of calibration images, was performed in 6:08min. Image preprocessing rcbf images were processed using FMRIB Software Library (FSL) software applications (http://www.fmrib.ox.a.c.uk/fsl) 6. For each participant, one Spoiled Gradient Recalled (SPGR) scan was used in the preprocessing steps in addition to
the T2 images acquired at the time of both CASL images (baseline and follow-up), which ensured that the normalization parameters applied to each scan were identical for each individual. A multi-step approach was performed as follows: (i) Extra-cerebral signal from the T2 scan was removed using the Brain Extraction Tool (BET) of FSL 7. The skull stripped T2 volume and its corresponding binary mask were then coregistered to the rcbf map. (ii) The coregistered binary mask was multiplied by the rcbf map to remove extra-cerebral signal from this scan. The skull stripped T2 and rcbf maps were then coregistered back to the space of the original T2 scan (returned to their original frame of reference). (iii) The follow-up T2 scan was coregistered to the baseline T2 scan, and the parameters applied to the follow-up skull stripped T2 mask and rcbf map, ensuring that all subsequent images were in the same subject specific space. (iv) The baseline T2 scan was subsequently coregistered to each subjects structural (SPGR) scan, with the coregistration parameters applied to the corresponding rcbf maps and brain extracted T2 scans at both baseline and follow-up time points. (v) The SPGR was normalized to MNI space using a non-linear approach using FNIRT 8 (FMRIB Non-linear Image Registration Tool) and the transformation matrix was applied to the rcbf map and the T2 scans. (vi) All data were then smoothed using a 6 mm Gaussian Smoothing kernel.
RESULTS Regional rcbf Anatomical localization for regional rcbf effects in basal ganglia, hippocampal and midbrain regions of interest are reported in Table S1. Whole Brain analysis: Ultra High Risk (UHR) vs. Controls (CTRL) At baseline the UHR group showed increased rcbf relative to controls across cortical and subcortical regions including bilateral frontal and prefrontal cortex, parietal and occipital cortices, lateral, medial and inferior temporal cortices, insula, cingulate cortex, cerebellum, striatum, brainstem and thalamus (Figure S1A and Table S2). There were no regions that showed increased rcbf in the CTRL relative to the UHR group. At the follow-up time point, relative to baseline, the UHR cohort showed a significant reduction in left prefrontal and right superior frontal gyrus rcbf (Figure S2B and Table S3). Antipsychotic (AP) free UHR subjects At baseline, relative to CTRL, AP free UHR subjects (n=45) showed increased rcbf in the hippocampus (p =.004), subiculum, putamen, pallidum ROI (p =.009), and midbrain (p =.02), bilaterally. These differences remained significant after controlling for the effect of global rcbf, age, gender, cigarettes per day and anxiety (HAM-A) scores. Whole brain analyses were qualitatively unchanged after removing AP medicated UHR subjects (Tables S2/3).
References 1. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic Resonance Imaging of Perfusion Using Spin Inversion of Arterial Water. Proceedings of the National Academy of Sciences USA. 1992;89:212-216. 2. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. Nov 1996;16(6):1236-1249. 3. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. Sep 1998;40(3):383-396. 4. Herscovitch P, Raichle ME. What is the correct value for the brain--blood partition coefficient for water? J Cereb Blood Flow Metab. Mar 1985;5(1):65-69. 5. Garcia D, Duhamel G, Alsop D. Efficiency of Inversion Pulses for Background Suppressed Arterial Spin Labeling. Magn Reson Med. 2005;54:366-372. 6. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23 Suppl 1:S208-219. 7. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. Nov 2002;17(3):143-155. 8. Andersson JLR JM, Smith S. Non-linear registration, aka spatial normalisation. FMRIB technical report TR07JA2. 2010.
Supplementary Figures Legend Figure S1: Whole brain activation maps (axial orientation) showing rcbf differences (Ultra High Risk > Controls) at baseline (a) and follow up (b) time points. The left of the image is the left of the brain.
Supplementary Tables Baseline: Ultra High Risk > Controls Basal ganglia Region of Interest R ventral putamen Cluster Z Size Statistic 216 4.62 P (FWE) x y z corrected 0.003 18 12 0 R pallidum 11 4.14 0.012 22-12 -4 L pallidum/putamen 153 4.82 0.001-18 -8-4 Hippocampal Region of Interest L hippocampus 41 4.35 0.003-30 -16-12 L subiculum/hippocampus 17 3.67 0.023-22 -28-8 R subiculum/hippocampus 26 4.24 0.004 20-28 -8 R anterior hippocampus 6 3.78 0.017 32-8 -22 Midbrain Region of Interest L midbrain 1116 5.39 <0.001-10 -32-18 Ultra High Risk: Baseline > Followup Basal Ganglia Region of Interest L caudate 91 4.46 0.004-16 -18 24 L putamen/pallidum 62 4.51 0.004-28 10 8 R caudate 6 3.68 0.024 20-2 22 Hippocampus Region of Interest L hippocampus 20 3.44 0.037-30 -32-8 Controls: Baseline > Follow-up No significant results Table S1. Anatomical localization of clusters showing significant effects with hippocampus, striatum and midbrain ROIs. The x, y, z coordinates of local maxima are listed according to the MNI coordinate system. All results p<.05 FWE cluster corrected.
Baseline (voxel wise): Ultra High Risk > Controls Cluster size Z statistic x y z L middle frontal gyrus 4278 5.73-51 16 26 R / L cingulate gyrus 1569 4.73-2 8 40 R cerebellum / lingual gyrus 1138 5.07 10-50 -8 L superior frontal gyrus 1034 5.12-10 52 34 brainstem 716 5.4-10 -22-26 L middle frontal gyrus 690 5.4-41 26 41 R precentral gyrus 625 4.61 36-14 46 R middle temporal gyrus 605 5.00 49 3-24 brainstem 598 5.27 10-28 -16 L planum polare/insula 462 4.91-40 -14-8 R inferior parietal lobule 385 5.04 52-34 42 R middle frontal gyrus 312 5.00 36 16 60 R caudate / putamen 337 4.62 18 12 0 R inferior temporal gyrus 287 5.24 54-60 -18 L cuneus 250 5.05-26 -81 28 R precentral gyrus 229 4.58 36-18 62 L lateral occipital cortex 216 5.02-48 -68-20 R middle occipital gyrus 198 4.41 34-73 20 R middle temporal gyrus 165 4.49 46-58 24 L thalamus 140 4.08-22 -18 2 Table S2: Anatomical localization of rcbf clusters (whole brain voxel wise analysis Ultra High Risk > Controls). The x, y, z coordinates of local maxima are listed according to the MNI coordinate system. All results p<.05 FWE cluster corrected (k >100)
Ultra High Risk: Baseline > Follow up Cluster size Z statistic X Y Z rcbf L frontal pole/inferior frontal gyrus 980 4.50-26 47-16 L frontal pole/middle frontal gyrus 280 4.16-44 44 28 R/L superior frontal gyrus 100 4.30 4 32 60 Table S3: Anatomical localization of rcbf cluster (whole brain voxel wise analysis) rcbf change between follow-up and baseline scans in UHR subjects. The x, y, z coordinates of local maxima are listed according to the MNI coordinate system. All results p<.05 FWE cluster corrected k >100
SD SD p Ultra High Risk in Follow-up N 30 22 Ultra High Risk lost to attrition Analysis Age (years) 21.50 3.56 23.54 (5.11) 5.11 t=1.70 0.1 NART FSIQ 104.10 11.32 98.29 (10.83) 10.83 t =-1.85 <.08 Yrs of School 11.95 0.97 11.90 (1.24) 1.24 t = 0.62,.87 Yrs post school 1.5 1.40.95 education 0.81.83 (1.4) t= -.05 Cigarettes per day 5.8 7.3 4.77 (6.39) 6.39 t = -.56.60 Cannabis use.52 (median) 2 2 Z = -.65 GAF score 56.76 9.59 58.68 (8.19) 8.19 t=.74.46 CAARMS total 42.03 16.01 37.45 (20.41) 20.41 t= -.89.37 CAARMS positive 7.56 3.89 6.72 (3.78) 3.78 t= -.77.44 CAARMS 4.60 3.9.50 negative 7.38 8.78 (3.9) t=.67 HAM-A 10.80 70 11.31 (4.69) 4.69 t =.30.76 Antipsychotic Medication (No. of subjects) 2 5 -- Gender Z=-0.34.30 Male 15 14 Female 15 8 Handedness Z=-0.56.40 Right 27 18 Left 3 4 Table S4: Participant demographic, clinical and medication data at baseline for Ultra High Risk participants that took part in follow-up study and Ultra High Risk participants that were lost to attrition (i.e. did not return for follow-up study). SD = Standard Deviation. NART FSIQ = National
Adult Reading Test Full Scale IQ. CAARMS = Comprehensive Assessment of At Risk mental State. GAF = Global Assessment of Function. Antipsychotic medication = 5 Quetiapine, 1 Risperidone, 1 Olanzapine.